Navigation Links
QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
Date:6/25/2012

o methods of analyzing DNA that began to emerge in the 1990s to improve upon earlier sequencing approaches that were time-consuming and laborious. Intelligent Bio-Systems' newer generation of sequencing by synthesis (SBS) technology incorporates proprietary advances in DNA sequence readout and DNA sample preparation, enabling low-cost, high throughput sequencing with high-quality data, making it attractive for customers.

QIAGEN forward-looking statement

Certain of the statements contained in this news release may be considered forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. To the extent that any of the statements contained herein relating to QIAGEN's products, markets, strategy or operating results, including without limitation its expected operating results, are forward-looking, such statements are based on current expectations and assumptions that involve a number of uncertainties and risks. Such uncertainties and risks include, but are not limited to, risks associated with management of growth and international operations (including the effects of currency fluctuations, regulatory processes and dependence on logistics), variability of operating results and allocations between customer classes, the commercial development of markets for our products in applied testing, personalized healthcare, clinical research, proteomics, women's health/HPV testing and nucleic acid-based molecular diagnostics; changing relationships with customers, suppliers and strategic partners; competition; rapid or unexpected changes in technologies; fluctuations in demand for QIAGEN's products (including fluctuations due to general economic conditions, the level and timing of customers' funding, budgets and other factors); our ability to obtain regulatory approval of our products; difficulties in successfully adapting QIAGEN's products to integ
'/>"/>

SOURCE QIAGEN N.V.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
2. BioDrain Medical, Inc. Implements Initiatives to Position Itself for Sustained Growth
3. Kansas City Region Launches Contract Research Initiative To Speed The Development Of Health Care Innovation Worldwide
4. Uroplasty Announces Product Development and New Clinical Trial Initiatives
5. Herborium Announces Continuing Progress In Key Strategic Initiatives
6. Warning: Not All Cold Sore Medicines Are Created Equal
7. Chinese Compulsory Immunization Program for Livestock Creates Massive Opportunity for Animal Vaccines and Biologics Developers
8. Kill the Germs, Spare the Ears: Study Shows How to Create Effective Antibiotics That Dont Damage Hearing
9. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
10. MicuRx Pharmaceuticals Announces Issuance Of U.S. Patent For Its Next-Generation Antibacterial Agent
11. Remedy Informatics to Debut SpecimenTrack, Next-Generation Biorepository Software at ISBER 2012 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2014)... (Nasdaq: CPHD ) today reported revenues for ... growth of 15% from $100.1 million for the third ... of 2014 was $(7.2) million, or $(0.10) per share, ... $(0.02) per share, in the third quarter of 2013.  ... debt discount and transaction costs, and amortization of purchased ...
(Date:10/16/2014)... 2014 Eight finalists, all representing outstanding innovation ... their proposals for a chance to compete for one ... Zayed Institute Second Annual Pediatric Surgical Innovation Symposium ... Friday, Oct. 24, 2014. Selected from a ... US and internationally, the finalists are: ...
(Date:10/16/2014)... , Oct. 16, 2014 Curtis & Coulter ... 3 weeks away from hosting their co-located Bioequivalence: ... Oral Drug Formulation Innovations Summit taking place on ... Diego, CA. November,s events are ... in streamlining the bioequivalence testing process, as well as ...
Breaking Medicine Technology:Cepheid Reports 2014 Third Quarter Results 2Cepheid Reports 2014 Third Quarter Results 3Cepheid Reports 2014 Third Quarter Results 4Cepheid Reports 2014 Third Quarter Results 5Cepheid Reports 2014 Third Quarter Results 6Cepheid Reports 2014 Third Quarter Results 7Cepheid Reports 2014 Third Quarter Results 8Cepheid Reports 2014 Third Quarter Results 9Cepheid Reports 2014 Third Quarter Results 10Cepheid Reports 2014 Third Quarter Results 11Cepheid Reports 2014 Third Quarter Results 12Cepheid Reports 2014 Third Quarter Results 13Cepheid Reports 2014 Third Quarter Results 14Cepheid Reports 2014 Third Quarter Results 15Cepheid Reports 2014 Third Quarter Results 16Cepheid Reports 2014 Third Quarter Results 17Finalists for Children's National Health System pediatric medical device competition announced 2Finalists for Children's National Health System pediatric medical device competition announced 3Finalists for Children's National Health System pediatric medical device competition announced 4Simplifying the Bioequivalence Testing Process and Optimizing Oral Formulation Development via Unifying the Global Life Science Community this November in San Diego 2
... PORTSMOUTH, N.H., Aug. 4, 2011 Novocure, a ... it has entered into a long-term supply agreement ... engineering and manufacturing conglomerate ITT Corporation (NYSE: ITT). ... ceramic components used to manufacture the disposable electrodes ...
... Texas, Aug. 4, 2011 Healthpoint Biotherapeutics today ... clinical trial investigating the efficacy of HP802-247 in ... living cell suspension containing keratinocytes and fibroblasts. The ... of two cell concentrations and two dosing frequencies ...
Cached Medicine Technology:Novocure Announces Long-Term Supply Agreement With ITT Corporation for Ceramic Sensor Technology 2Novocure Announces Long-Term Supply Agreement With ITT Corporation for Ceramic Sensor Technology 3Positive Results for Phase IIb Trial of Unique Cell-Based Therapy in Venous Leg Ulcers 2Positive Results for Phase IIb Trial of Unique Cell-Based Therapy in Venous Leg Ulcers 3Positive Results for Phase IIb Trial of Unique Cell-Based Therapy in Venous Leg Ulcers 4
(Date:10/19/2014)... SweetDressy.com, a professional company of women’s dresses ... long evening dresses . All the company’s old ... current discount is up to 66 percent off. ... the fashion field. Its dress specialists are striving to ... parts of the world. All the company’s items are ...
(Date:10/19/2014)... stem cell-based research could improve understanding of intestinal diseases ... suggests. Scientists used stem cells to grow "organoids" ... They then transplanted the organoids into mice, creating a ... researchers. "This provides a new way to study ... failure, from genetic disorders appearing at birth to conditions ...
(Date:10/19/2014)... The federal litigation involving GranuFlo ... forward in Massachusetts federal court, where more than ... dialysis medication, Bernstein Liebhard LLP reports. , ... 2,127 claims now filed over GranuFlo and NaturaLyte ... District Court, District of Massachusetts. Plaintiffs in these ...
(Date:10/19/2014)... DENVER (October 20, 2014) - As Alaska ... the outright legalization of recreational marijuana for adults, Ryan ... in those states and elsewhere in America: make sure ... chaos. , Fox is founder and CEO of The ... first recreational dispensaries. , The Grass Station also ...
(Date:10/19/2014)... October 19, 2014 According to the ... the vast majority of adults (up to 90 ... in their lives, spending at least $50 billion on ... includes; spinal instability, stenosis, spondylolisthesis, and symptomatic degenerative disc ... wear and tear associated with the aging process, but ...
Breaking Medicine News(10 mins):Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2Health News:Scientists Grow, Implant Human Intestinal Tissue in Mice 2Health News:More than 2,100 GranuFlo Lawsuits Now Filed in Federal Dialysis Drug Litigation, Bernstein Liebhard LLP Reports 2Health News:More than 2,100 GranuFlo Lawsuits Now Filed in Federal Dialysis Drug Litigation, Bernstein Liebhard LLP Reports 3Health News:More than 2,100 GranuFlo Lawsuits Now Filed in Federal Dialysis Drug Litigation, Bernstein Liebhard LLP Reports 4Health News:Cannabis CEO Warns Those States Considering a Legal Marijuana Market to Do Their Homework First 2Health News:Cannabis CEO Warns Those States Considering a Legal Marijuana Market to Do Their Homework First 3Health News:Santa Rosa Orthopaedic (SRO) Opens the Total Spine Health Program in the North Bay – Offering Quality Care for Low Back Pain 2Health News:Santa Rosa Orthopaedic (SRO) Opens the Total Spine Health Program in the North Bay – Offering Quality Care for Low Back Pain 3Health News:Santa Rosa Orthopaedic (SRO) Opens the Total Spine Health Program in the North Bay – Offering Quality Care for Low Back Pain 4Health News:Santa Rosa Orthopaedic (SRO) Opens the Total Spine Health Program in the North Bay – Offering Quality Care for Low Back Pain 5
... a special protein responsible for cell development (Notch) ... new study shows. ,“Breast cancer cells ... by commonly used hormonal therapy, by increasing the ... Miele, professor, departments of pathology, pharmacology and experimental ...
... basis of recent studies that the commonly employed //chemotherapy ... ,AC/T, a widely accepted chemotherapy might be ... which has been proven to be more efficient in ... also has been proven to be far superior to ...
... doctoral thesis from Karolinska Institutet, our everyday environments are ... degrees when inhaled. Particularly damaging to our cellular DNA ... Sweden. ,"Luckily, most of them do ... time," says scientist Hanna Karlsson. "However, particle levels are ...
... developed a new anti-aging ingredient known as GGC, which ... early next year. // ,GGC is a precursor ... a broad range of potential health benefits. Glutathione is ... in cancer, diabetes, aging and other diseases and degenerative ...
... Madhya Pradesh took part in an AIDS awareness campaign and ... ,The students tied 'suraksha bandhan' (protection bands) on ... their commitment to spread this awareness. ,The students ... of Journalism here as part of a 'Unite for Children, ...
... frozen ready meals including 20 Asda own brand, 4 Sainsbury’s ... may contain small pieces of glass. Customers are also being ... ,The products came from Rye Valley Foods in Carrickmacross, a ... the country's biggest food processors. The company said pieces of ...
Cached Medicine News:Health News:Study Identifies Mechanism Which May Help Tamoxifen Work Better 2Health News:Underground Air - Associated With - DNA Damages 2
... This functional brace is designed for the ... and fibula. The preformed design provides post ... removal of internal or external fixation. The ... and below the fracture site, increasing vascularity ...
... Brace features a multi-axial hinge that duplicates ... altering kinematics. The infinite degree of adjustment ... and extension control of the knee. , ... tibia in correct anatomical alignment. The precision ...
... is a revolutionary cast replacement system for ... leg and foot. , ,A self-adjusting ... and in conjunction with a rigid lattice ... time of fracture or rupture healing can ...
... the constant demands of mobilizing patients quickly. ... necessary to fit bilateral KAFO's.,The complete kit ... knee joints , 4 Copolymer thigh support ... bands , Ortho-wick™ Padding for thigh , ...
Medicine Products: